Siatis Perry C's Form 4 filing
AbbVie Inc. (ABBV) · filed Feb 27, 2026
- Accession no.
- 0001951400-26-000004
- Filed
- Feb 27, 2026
- Trade date
- Feb 25, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $5.15M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Siatis Perry CCIK 0001951400 | Officer (EVP, GC AND SECRETARY) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 25, 2026 | Common Stock, $0.01 par value | MOption exerciseAcquired | +7,314 | $149.62 | +$1,094,320.68 | 45,451 | Direct | |
| Feb 25, 2026 | Common Stock, $0.01 par value | MOption exerciseAcquired | +7,775 | $175.28 | +$1,362,802 | 53,226 | Direct | |
| Feb 25, 2026 | Common Stock, $0.01 par value | MOption exerciseAcquired | +7,292 | $192.86 | +$1,406,335.12 | 60,518 | Direct | |
| Feb 25, 2026 | Common Stock, $0.01 par value | SSaleDisposed | −22,381 | $230.00 | −$5,147,630 | 38,137 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 25, 2026 | Common Stock | MOption exerciseDisposed | −7,314 | $149.62 | −$1,094,320.68 | 0 | Direct | |
| Feb 25, 2026 | Common Stock | MOption exerciseDisposed | −7,775 | $175.28 | −$1,362,802 | 7,774 | Direct | |
| Feb 25, 2026 | Common Stock | MOption exerciseDisposed | −7,292 | $192.86 | −$1,406,335.12 | 14,583 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.